APA (7th ed.) Citation

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., . . . Aghajanian, C. (2023). Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer. The New England journal of medicine, 388(23), 2159-2170. https://doi.org/10.1056/NEJMoa2302312

Chicago Style (17th ed.) Citation

Eskander, Ramez N., et al. "Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer." The New England Journal of Medicine 388, no. 23 (2023): 2159-2170. https://doi.org/10.1056/NEJMoa2302312.

MLA (9th ed.) Citation

Eskander, Ramez N., et al. "Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer." The New England Journal of Medicine, vol. 388, no. 23, 2023, pp. 2159-2170, https://doi.org/10.1056/NEJMoa2302312.